QDEL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
QuidelOrtho Corp (QDEL) is not a good buy for a beginner investor with a long-term focus at this time. The stock is underperforming, with weak financials, negative news sentiment, and lack of strong positive catalysts. While insider buying is a positive signal, the overall outlook remains unfavorable given the company's declining revenue, bearish technical indicators, and reduced analyst price targets.
The technical indicators are bearish. The MACD is above 0 but contracting, indicating weakening momentum. The RSI is neutral at 31.356, and the moving averages suggest a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its key support level of 12.599, with resistance levels at 15.038 and 17.478.
Insiders are buying, with a significant 2578.44% increase in buying activity over the last month.
The company reported weak Q1 2026 revenue projections due to a 30% decline in U.S. influenza-like illness visits, reimbursement challenges in China, and order delays from the Middle East conflict. Analysts have lowered price targets, and the stock has experienced an 11% drop in after-hours trading following the revenue announcement.
The company's financial performance has been weak. In Q3 2025, revenue dropped by 3.74% YoY to $699.9 million. Net income increased significantly but remains negative at -$733 million. EPS improved but is still negative at -10.78. Gross margin slightly declined to 41.13%.
Analyst sentiment is neutral to bearish. UBS recently lowered its price target to $17 from $30, citing mixed 2026 guidance. Other analysts have maintained neutral or underweight ratings, with price targets ranging from $17 to $30.
